Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of ...
The FDA has approved Simtriyo (centanafadine), a first-in-class NDSRI and CNS stimulant, for adult and pediatric ADHD aged 6 years and older.
Families in the Midwest and beyond can access this through a PANDAS specialist who offers exactly this kind of records review ...
Hello everybody, and welcome to the Q2 2026 Teva Pharmaceutical Industries Earnings Conference Call. My name is Elliot. I'll be coordinating your call today. [Operator Instructions] I would now like ...
MedPage Today on MSN
First-in-Class Drug for ADHD Wins FDA Approval
Triple reuptake inhibitor centanafadine is indicated for patients ages 6 years and older ...
Authorisation from MRHA and Recommendation from NICEThis announcement is intended for business and financial media and investors only SOUTH SAN ...
1don MSNOpinion
This is why it seems like everyone has ADHD right now
'Isn't it normal to get a little bit distracted sometimes?' ...
3d
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
The conference call will be broadcast live in listen-only mode via webcast at https://edge.media-server.com/mmc/p/7ri4xna9. To listen to the conference call on your telephone, participants may ...
Prebiotics feed beneficial gut bacteria, while probiotics add them. Doctors say a balanced, fibre-rich diet matters more than ...
Introduction Mental health conditions are prevalent during adolescence, but access to early evidence-based treatments remains ...
A man with a history of sexual exhibitionism and indecent acts should be sentenced to nine months in jail, a Crown prosecutor argued.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results